Literature DB >> 6089348

Human T-cell leukemia virus (HTLV-I) antibodies in Africa.

W Saxinger, W A Blattner, P H Levine, J Clark, R Biggar, M Hoh, J Moghissi, P Jacobs, L Wilson, R Jacobson.   

Abstract

Antibodies specific for human T-cell leukemia-lymphoma virus type I (HTLV-I) were demonstrated in serum samples from various groups of people in South Africa, Uganda, Ghana, Nigeria, Tunisia, and Egypt. The samples had been collected for other purposes and were presumably selected without bias toward clinical conditions associated with HTLV infections. Regional differences in antibody positivity were observed, indicating widely distributed loci of occurrence of HTLV on the African continent in people of both black and white ancestry. Two patients with high titers of antibody to HTLV-I had some signs of adult T-cell leukemia-lymphoma. In several groups a high frequency of false positive serum reactions was indicated when specific confirmation steps were included in the assay. Further characterization of these sera revealed highly elevated immunoglobulin levels, possibly due to polyclonal activation of immunoglobulin synthesis in these subjects. The possibility that related cross-reactive human retroviruses coexist in the same groups was not eliminated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089348     DOI: 10.1126/science.6089348

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

1.  HTLV-I infection in French West Indies: a case-control study.

Authors:  N Frery; M Chavance; I Valette; L Schaffar; C Neisson-Vernant; J Jouannelle; N Monplaisir
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

2.  A serosurvey for HTLV-I among high-risk populations and normal adults in Egypt.

Authors:  N T Constantine; M Fathi Sheba; A L Corwin; R S Danahy; J D Callahan; D M Watts
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

Review 3.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

4.  Immune impairments and antibodies to HTLVIII/LAV in asymptomatic male homosexuals in Israel: relevance to the risk of acquired immune deficiency syndrome (AIDS).

Authors:  Z Bentwich; C Saxinger; Z Ben-Ishay; R Burstein; Y Berner; M Pecht; N Trainin; S Levin; Z T Handzel
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

5.  Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes.

Authors:  S P Parker; M B Taylor; A E Ades; W D Cubitt; C Peckham
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

6.  Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.

Authors:  Ayse Kubra Coskun; Richard E Sutton
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 7.  Evidence for a Euro-American origin of human immunodeficiency virus (HIV).

Authors:  H P Katner; G A Pankey
Journal:  J Natl Med Assoc       Date:  1987-10       Impact factor: 1.798

8.  Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.

Authors:  L Delamarre; C Pique; D Pham; T Tursz; M C Dokhélar
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea.

Authors:  M P Sherman; N K Saksena; D K Dube; R Yanagihara; B J Poiesz
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Isolation and characterization of simian T-cell leukemia virus type II from New World monkeys.

Authors:  Y M Chen; Y J Jang; P J Kanki; Q C Yu; J J Wang; R J Montali; K P Samuel; T S Papas
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.